Pfizer and Flynn accused of overcharging NHS for anti-epilepsy drugs
Competition regulator the CMA alleges drugs firms abused dominant position with unfairly high prices Pharmaceutical companies Pfizer and Flynn have been accused by the UK’s […]
Pfizer
Lilly has a bad hair day as Pfizer rival hits the mark in alopecia
Eli Lilly and Incyte have another rival in the rear-view mirror for Olumiant in alopecia areata after Pfizer reported that its ritlecitinib improved scalp hair […]
UK extends COVID vaccination to 16 and 17-year-olds
The UK government has confirmed that the national COVID-19 vaccination campaign will be extended to include 16 and 17-year-old children, to tackle an increase in […]
Germany confirms booster COVID jabs will start in September
Germany’s health ministry has said it will start offering booster COVID-19 vaccines to vulnerable people from next month, amid concerns about rising cases of the […]
As Delta spreads, Pfizer and Moderna get set for a booster shot to profits
The firms are already taking the lion’s share of earnings from the market, as this week’s results will show Praised for preventing hundreds of thousands […]
AstraZeneca sales of Covid vaccine triple to $1.2bn in first half of 2021
Not-for-profit pledge sees British firm’s sales revenue fall significantly short of US rival Pfizer Coronavirus – latest updates See all our coronavirus coverage AstraZeneca’s Covid-19 […]
Major delay in federal government’s Novavax deal, with 51m doses not expected until 2022
Initially touted as a ‘primary’ vaccine to help immunise Australia by the end of this year, Novavax will now form part of the booster strategy […]
Study finds jabs cut severe variant COVID disease after one shot
A real-world study carried out in Canada had found that COVID-19 vaccines from AstraZeneca, Pfizer/BioNTech and Moderna reduce the chances of being hospitalised or dying […]
Pfizer commits $1B to Arvinas for share of protein degrading breast cancer drug
Arvinas’ early clinical data for its targeted protein degradation drug for breast cancer drew partnering interest from several companies. Pfizer beat them all with a […]
Pfizer puts up $1bn to buy into Arvinas breast cancer programme
Pfizer has pledged a whopping $11 billion upfront for rights to an Arvinas drug for breast cancer from its protein degrader platform, which harnesses cells’ […]
FDA okays Merck’s would-be Prevnar rival Vaxneuvance
The FDA has approved a new pneumococcal vaccine from Merck & Co, just over a month after Pfizer got a green light for a new […]
Shot in the arm for Affinivax as it challenges Pfizer’s Prevnar
Already facing one rival to its blockbuster pneumococcal vaccine Prevnar, Pfizer could have another to contend with, after Affinivax reported positive phase 2 results with […]
US officials call for more data on vaccine boosters as Pfizer pushes for third shot
• Pharma company presses case with senior health officials • WHO urges priority for nations with low Covid vaccination rates Pfizer, the pharmaceutical company that […]
Pfizer pushes for booster shots as WHO says greed is driving vaccine disparities
• Pharmaceutical company seeks FDA approval for third dose • Companies urged to instead prioritise less wealthy countries After a sharp increase in US Covid […]
Morrison government silent on contact with Pfizer global chief after Kevin Rudd intervenes in vaccine talks
Under fire for his government not reaching out to the pharmaceutical giant’s international head, health minister Greg Hunt also avoided naming the former Labor PM […]
Eyeing delta surge, Pfizer will file COVID-19 booster next month
With the COVID-19 delta variant has become the dominant strain circulating in the US, Pfizer and BioNTech have said they will ask the FDA and […]
Israel says Pfizer jab less effective against COVID-19 delta
The Israeli Ministry of Health has reported data suggesting that the efficacy of the Pfizer/BioNTech COVID-19 vaccine has become less effective at preventing the spread […]
Spero Therapeutics Enters into a License Agreement with Pfizer for SPR206 to Treat MDR Gram Negative Infections
Shots: Spero is eligible to receive $40M as an equity investment and ~$80M as development & sales milestones along with royalties on sales of SPR206 […]
Million Pfizer jabs face being dumped after Israel-UK swap deal fails
Israel says technical issues have scuppered deal to give UK Covid vaccines expiring on 30 July Coronavirus – latest updates See all our coronavirus coverage […]
PharmaShots’ Key Highlights of Second Quarter 2021
The second quarter of 2021 witnesses major acquisitions, approvals, and clinical data. There are major alliances in this quarter which include Merck signed ~$1.2B supply […]
Moderna, Pfizer or AstraZeneca? The ridiculous, diverting rise of vaccine envy
Casual vaccine chat is today’s only form of small talk, so it’s not surprising it would take a lightheartedly tribal turn. Ultimately, of course, gratitude […]
Covid jabs for billions of humans will earn their makers billions of dollars
We look at the drug firms – led by Pfizer and Moderna – that are set to profit most in an unprecedented global vaccination drive […]
PharmaShots Weekly Snapshots (June 14 – 18, 2021)
Lineage Signs an Exclusive Option Agreement with Amasa Therapeutics to Supply and Use of Clinical-Grade Hystem Published: June 18, 2021 | Tags: Lineage, Option Agreement, […]
Pfizer Presents Results of Tofacitinib in STOP-COVID Study for Patients Hospitalized with COVID-19 Pneumonia at NEJM
Shots: The STOP-COVID study was conducted with a research collaboration b/w Pfizer & an ARO in Brazil, evaluating the efficacy & safety of tofacitinib (10mg, […]
PharmaShots Weekly Snapshots (June 07 – 11, 2021)
Vertex and CRISPR Therapeutics Present New Data of CTX001 from 22 Patients with TDT and SCD at EMA 2021 Published: June 11, 2021 | Tags: […]
US orders 500m Pfizer/BioNTech COVID jabs for developing nations
The US government will buy 500 million more doses of the Pfizer/BioNTech COVID-19 vaccine that will be given to around 100 countries via the COVAX […]
Pfizer’s Prevnar 20 wins FDA nod, getting edge in pneumococcus vax race—for now
The FDA has approved Prevnar 20, a Pfizer vaccine that protects against 20 pneumococcal strains—seven more than the company’s blockbuster Prevnar 13. But others are […]
FDA clears Pfizer’s Prevnar 20 for adults, as Merck rival nears decision
Pfizer has the FDA approval it was seeking for Prevnar 20, the latest update to its blockbuster pneumococcal vaccination franchise, keeping it one step ahead […]
Pfizer’s Prevnar 20 (Pneumococcal 20-Valent Conjugate Vaccine) Receives the US FDA’s Approval for the Prevention of Invasive Disease and Pneumonia
Shots: The approval is based in the clinical program including P-I & II trials, and three P-III trials evaluating the safety & immunogenicity of Prevnar […]
PharmaShots Weekly Snapshots (May 31 – June 4, 2021)
Tonix Pharmaceuticals Presents Results of TNX-102 SL in P-III RELIEF study for the Management of Fibromyalgia at ASCP 2021 Published: June 4, 2021 | Tags: […]
Fears of side-effects fuel reluctance to get Covid jabs, survey finds
Imperial College London survey in 15 countries also reveals worries that vaccines had not been tested enough Coronavirus – latest updates See all our coronavirus […]
Pfizer and BioNTech Receive EC’s Conditional Marketing Approval for the COVID-19 Vaccine in Adolescents
Shots: The approval is based on a P-III study assessing Comirnaty (two 30μg doses) in 2,260 participants aged 12-15yrs. and showed 100% efficacy in participants […]
PharmaShots Weekly Snapshots (May 24 – 28, 2021)
Seelos’ SLS-005 (Trehalose) Receives EC’s Orphan Drug Designation to Treat Amyotrophic Lateral Sclerosis Published: May 28, 2021 | Tags: Seelos, SLS-005, Trehalose, EC, Orphan Drug […]
Chasing Lilly, Concert eyes 2023 filing for its JAK drug for alopecia
Concert Pharmaceuticals has started the second of two planned phase 3 trials of its drug candidate for alopecia areata (AA), a common cause of hair […]
Myovant hormonal therapy gets FDA nod, setting up competition with AbbVie
Myovant hormonal drug Myfembree has won FDA approval as a treatment for uterine fibroid bleeding. The regulatory decision clears the way for the pill to […]
FDA clears Myovant’s relugolix for uterine fibroids, setting up AbbVie clash
Myovant has chalked up a second approval for its flagship drug relugolix from the FDA, becoming the first once-daily oral drug in the US to […]
Pfizer and Myovant’s Myfembree Receive the US FDA’s Approval for Heavy Menstrual Bleeding Associated with Uterine Fibroids
Shots: The approval is based on efficacy and safety data from the P-III LIBERTY 1 & 2 studies assessing Myfembree (relugolix 40 mg, estradiol 1 […]
Moderna will file COVID-19 jab for teens after trial shows 100% protection
Moderna’s COVID-19 vaccine has joined the Pfizer/BioNTech jab in showing efficacy in younger patients in clinical trials, setting up an emergency use filing early next […]
Moderna jab stops Covid transmission in people aged 12 to 18, trial finds
Moderna becomes second manufacturer to announce successful trial results in younger people Coronavirus – latest updates See all our coronavirus coverage Mass vaccination of children […]
Safety of mRNA COVID-19 jabs backed, despite myocarditis cases
As US and EU health regulators review cases of heart inflammation seen in young people administered mRNA-based COVID-19 vaccines from Pfizer/BioNTech and Moderna, cardiologists have […]
Pfizer Initiates Study to Evaluate its Pneumococcal Vaccine with Booster dose of its COVID-19 Vaccine
Shots: The first enrolled patient has received their immunizations as part of a new study in adults ≥65yrs. evaluating the coadministration of 20vPnC with a […]
UK says Pfizer, AZ COVID-19 vaccines work against Indian variant
People who have received two doses of the AstraZeneca or Pfizer/BioNTech COVID-19 vaccines have good protection against the Indian variant of SARS-CoV-2 , according to […]
UK booster trial will test value of third COVID jab dose
All seven COVID-19 vaccines ordered by the UK government will be tested in a new trial that will see whether they can be used as […]
PharmaShots Weekly Snapshots (May 10 – 14, 2021)
AzurRx BioPharma Reports Positive Interim P-II Data of MS1819 + PERT for Cystic Fibrosis Patients with Severe Exocrine Pancreatic Insufficiency Published: May 14, 2021 | […]
Delay in giving second jabs of Pfizer vaccine improves immunity
Study finds antibodies against Sars-CoV-2 three-and-a-half times higher in people vaccinated again after 12 weeks rather than three Coronavirus – latest updates See all our […]
First UK patient joins Pfizer’s phase 3 DMD gene therapy trial
The first UK patient has enrolled on Pfizer’s phase 3 trial for its Duchenne muscular dystrophy (DMD) gene therapy. Pfizer’s CIFFREO study began in the […]
Pfizer warns Australia a Covid vaccine patent waiver could harm supply and safety
The pharmaceutical giant argues waiving intellectual property protections could see scarce inputs snapped up making it harder to produce vaccines Full Story podcast: Is Australia […]
FDA authorises Pfizer/BioNTech vaccine for adolescents
The FDA has authorised Pfizer/BioNTech’s vaccine for 12- to 15 year-olds under emergency rules. In a statement the regulator said it had expanded the vaccine’s […]
Pfizer and BioNTech Receive the US FDA’s EMA for COVID-19 Vaccine in Adolescents
Shots: The FDA has expanded the EUA for Pfizer’s COVID-19 vaccine in adolescents based on the data from the P- III trial in 2,260 participants […]
FDA authorizes Covid vax for teens; plans June meeting for all pediatric vaccines
The FDA has expanded emergency use of the Pfizer/BioNTech Covid-19 vaccine to include children 12 to 15 years of age. Meanwhile, the regulator is planning […]
EMA panel probes heart inflammation with Pfizer/BioNTech COVID vaccine
A review of side effects reported with coronavirus vaccines by the EMA’s safety committee has uncovered cases of inflammation of the heart in people receiving […]
Pfizer, BioNTech seek full FDA approval of Covid-19 vaccine
The messenger RNA vaccine developed by Pfizer and BioNTech has been formally submitted for FDA approval. The application comes amid calls for all vaccine companies […]
Pharmaceutical firms’ shares tumble after US plans patent waiver on Covid vaccines
Shares in Chinese and US companies fell sharply following announcement to boost production Coronavirus – latest updates See all our coronavirus coverage Shares in pharmaceutical […]
Pfizer shares slump as support grows for COVID-19 vaccine patent waiver
Shares in COVID-19 vaccine manufacturers have taken a hit after the US signalled its support for waiving patents on them, a moved aimed to boost […]
Pfizer says COVID-19 jab could rake in $26bn this year
Pfizer expects revenues from its BioNTech-partnered COVID-19 vaccine to reach an eye-watering $26 billion this year, catapulting it to the top of the world’s biggest-selling […]
Pfizer forecasts $26bn from annual sales of Covid-19 vaccine
Vaccine will generate 73% more than forecast based on contracts signed until mid-April Coronavirus – latest updates See all our coronavirus coverage US drugmaker Pfizer […]
Alphamab and Pfizer Initiate P-II Trial Evaluating KN046 + Inlyta (axitinib) as a 1L Treatment of Non-Small Cell Lung Cancer
Shots: The P-II trial will evaluate the efficacy, safety, and tolerability of KN046 + Pfizer’s Inlyta (axitinib) as a 1L treatment of NSCLC. The 1EPs […]
India wants access to cheap copies of Covid vaccines. So why is Australia holding out?
More than 100 countries are pushing for a temporary waiver of IP rules to boost vaccine access for developing nations. Why hasn’t it been approved? […]
UK orders 60m ‘booster’ doses of Pfizer/BioNTech COVID vaccine
The UK has ordered an extra 60 million doses of the Pfizer/BioNTech COVID-19 vaccine, which could be used as a potential booster campaign in the […]
UK orders 60m more doses of Pfizer Covid vaccine for booster jabs
Health secretary says greater supplies of vaccine will help safeguard progress in tackling coronavirus Coronavirus – latest updates See all our coronavirus coverage The UK […]
Pfizer acquires Amplyx Pharma in bid to shore up its antifungal drug pipeline
Amplyx Pharmaceuticals brings Pfizer a clinical-stage antifungal candidate with a novel mechanism of action. The pharmaceutical giant is trying to build its antifungal product lineup, […]
ViewPoints Interview: Pyxis Oncology’s Dr. Lara S. Sullivan and Dr. Ronald Herbst Share Insights on the Importance of Series B Funding to Advance their Portfolio
In an interview with PharmaShots, Dr. Lara S. Sullivan, Chief Executive Officer, and Dr. Ronald Herbst, Chief Scientific Officer of Pyxis Oncology share insight on […]
What Covid vaccines does the UK have and which are in the works?
As Valneva recruits volunteers for final stage trials of its vaccine, here is the current state of play in Britain Coronavirus – latest updates See […]
PharmaShots’ Key Highlights of First Quarter 2021
The first quarter of 2021 highlights new approvals, M&A, and the clinical data of COVID-19 vaccines. The companies expand their working in COVID-19 by targeting […]
UK Vaccine Taskforce head lifts lid on Novavax deal
The UK’s unique offering as a life sciences research hub helped convince US biotech Novavax to develop its COVID-19 jab there, according to the head […]
EU orders another 100m doses of Pfizer/BioNTech COVID jab
The EU has continued a refocus of its COVID-19 vaccination drive on mRNA shots, ordering another 100 million doses of Pfizer and BioNTech’s Comirnaty shot. […]
Risk of brain clots higher with COVID than vaccine, study suggests
A study has suggested that the risk of getting a serious brain clot is eight to 10 times higher in people with COVID-19 than those […]
Covid booster shot warning ‘underlines urgent need for Australia to make mRNA vaccines’
Pfizer boss flags likelihood that extra jabs will be required – raising prospect of increased global demand Covid booster shot could be needed after nine […]
Will Covid vaccines protect us against new variants? | Julian Tang
New strains such as the South African variant that’s emerged in south London will require constant vigilance as lockdown eases All viruses mutate. They do […]
Pfizer/Myovant take relugolix contraceptive combination pill into phase 3
Pfizer and Myovant have begun a late-stage trial of their potential uterine fibroid drug relugolix, as part of a contraceptive combination tablet. The FDA is […]
AZ aims at Pfizer, GSK with potential new PARP cancer drug
AstraZeneca’s Lynparza (olaparib) blazed a trail for the new class of PARP drugs when it was approved in 2014 to treat ovarian cancer. The drug […]
South African variant may evade Pfizer/BioNTech vaccine, study finds
The coronavirus variant discovered in South Africa may evade Pfizer/BioNTech’s vaccine, according to a real-world data study conducted in Israel. Known as variant B.1.351, the […]
What does Australia’s new advice on the AstraZeneca Covid vaccine mean and what is the risk?
Experts say the development of blood clots after getting the jab is still an ‘exceedingly rare’ side effect. So what triggered the government’s change in […]
Top 20 BioPharma Companies based on 2020 Total Revenue
Despite having the global pandemic, the biopharma companies were involved in multiple M&A, licensing deals. The major focus of the year remains the production and […]
Two new vaccines on the way – with more to follow this year
Half of UK adults have had a first jab, and future supplies of millions of doses look assured Coronavirus – latest updates See all our […]
PharmaShots Weekly Snapshots (Mar 29 – Apr 02, 2021)
Pfizer and BioNTech Report Results of BNT162b2 to Prevent COVID-19 Published: Apr 2, 2021 | Tags: Pfizer and BioNTech, Report, Results, BNT162b2, Prevent, COVID-19 Acceleron […]
Pfizer vaccine has 91% efficacy for up to six months, trial shows
Findings based on two doses three weeks apart are first to show shot remains effective for many months Coronavirus – latest updates See all our […]
Insights+ Key Biosimilars Events of March 2021
Biosimilars are developed to be highly similar versions of approved biologics in terms of safety, purity, and potency Biosimilars are expected to be a cost-effective […]
Pfizer & BioNTech report Covid-19 vaccine shows 100% efficacy in kids 12 to 15
Based on the efficacy and safety data for their Covid-19 vaccine in younger teens, Pfizer and BioNTech plan to ask regulators to expand emergency authorization […]
Pfizer finds Covid vaccine safe and effective for children 12 to 15
Drug firm in partnership with BioNTech to seek US approval after trials found vaccine ‘well-tolerated’ in school-age children Pfizer plans to seek emergency approval for […]
How the AstraZeneca vaccine became a political football – and a PR disaster
Newly accused of data manipulation by the US, AstraZeneca has faced unprecedented scrutiny over the past six months Coronavirus – latest updates See all our […]
Thumbs-down from FDA experts for Pfizer/Lilly’s painkiller tanezumab
After more than a decade of fraught clinical development it looks like the end of the line for Pfizer/Lilly painkiller tanezumab, which promised to be […]
Pfizer begins clinical trials of COVID-19 antiviral pill
Pfizer has begun clinical development of an antiviral pill against COVID-19, which could be prescribed to patients at the first sign of infection. The company […]
FDA worried about Pfizer/Lilly pain drug safety ahead of key meeting
After a long and troubled development the fate of Pfizer/Lilly’s tanezumab painkiller injection is in the balance ahead of a key meeting of advisers later […]
The Guardian view on pandemic politics: we need cooperation, not confrontation | Editorial
Vaccinating the world is the only way out of Covid, but a mixture of nationalism and protectionism is blocking the exit Covid-19 has proved to […]
PharmaShots Weekly Snapshots (Mar 15 – 19, 2021)
Takeda Collaborates with Anima to Discover and Develop mRNA Translation Modulators for Neurological Diseases Published: Mar 19, 2021 | Tags: Takeda, Collaborates, Anima, Discover, Develop, […]
PharmaShots Weekly Snapshots (Mar 15 – 19, 2021)
Takeda Collaborates with Anima to Discover and Develop mRNA Translation Modulators for Neurological Diseases Published: Mar 19, 2021 | Tags: Takeda, Collaborates, Anima, Discover, Develop, […]
Pfizer Signs a WW License Agreement with Pyxis to Develop and Commercialize Two ADC Candidates
Shots: Pfizer to receive an up front, equity in Pyxis and is eligible for development & commercial milestones as well as royalties on potential sales […]
Pfizer Signs a WW License Agreement with Pyxis to Develop and Commercialize Two ADC Candidates
Shots: Pfizer to receive an up front, equity in Pyxis and is eligible for development & commercial milestones as well as royalties on potential sales […]
3 Ways Providers Can Navigate COVID-19 Vaccination Rollout Successfully
Lisa Romano, MSN, RN, Chief Nursing Officer at CipherHealth The New Year brings hope and promises that an end to the COVID-19 pandemic is in […]
Regulators questioned integrity of Pfizer/BioNTech vaccine, leaked files show
European regulators questioned the integrity of early batches of Pfizer/BioNTech’s mRNA vaccine, although the matter was resolved before approval, according to information leaked online following […]
Harris Poll Finds Large Boost in Pharma Industry Reputation
As the COVID-19 vaccine roll-out gains in intensity, it has become common to hear people toss out the names of pharmaceutical companies like Pfizer, Moderna […]
EU probes low platelet safety issue with COVID-19 shots
EU regulators are reviewing reports of low blood platelets in patients who received any of the three approved COVID-19 vaccines from Pfizer/BioNTech, AstraZeneca and Moderna. […]
Sanofi/Translate start clinical trial of mRNA COVID shot
Sanofi and Translate BIO have begun a clinical trial of their potential mRNA COVID-19 shot, as the French pharma struggles to keep pace with rivals […]
Israeli real-world data on Pfizer vaccine shows high Covid protection
Jab has 97% efficacy against disease and death and 94% against infection without symptoms The Pfizer/BioNTech vaccine appears to give high protection against asymptomatic Covid-19, […]
Insights+: Breakthrough Therapy Designation by the US FDA in 2020
Breakthrough Therapy (BT) Designation is an expedited review program introduced in Section 902 of the Food and Drug Safety and Innovation Act of 2012 The […]
J&J manufacturing delays hit US vaccine rollout
The rollout of the US COVID-19 vaccination programme slowed up this week because manufacturing delays mean no new doses of the recently approved Johnson & […]
Pfizer/BioNTech COVID jab works against Brazil variant; lab study
A laboratory study suggests Pfizer and BioNTech’s COVID-19 vaccine Comirnaty could be effective against a Brazilian variant of the SARS-CoV-2 virus – known as P.1 […]
BioNTech co-founder says gender equality made vaccine possible
Özlem Türeci credits firm’s more than 50% female workforce for speed at which first viable jab created The co-founder and chief medical officer of BioNTech […]
From Pfizer to Moderna: who’s making billions from Covid vaccines?
The companies in line for the biggest gains – and the shareholders who have already made fortunes Coronavirus – latest updates See all our coronavirus […]
PharmaShots Weekly Snapshots (Mar 01 – 05, 2021)
Eli Lilly and Incyte Report Results of Olumiant (baricitinib) in P-III BRAVE-AA2 Study for Severe Alopecia Areata Published: Mar 5, 2021 | Tags: Eli Lilly […]
Pfizer’s Lorbrena (lorlatinib) Receives FDA’s Approval for Expanding its Indication to Treat ALK-Positive Metastatic Lung Cancer
Shots: The approval is based on P-III CROWN study assessing Lorbrena vs Xalkori (crizotinib) monthx in 296 people in a ratio (1:1) with prior untreated […]
First Databank Clinician Addresses COVID-19 Vaccine Skepticism – Q/A
Joan Kapusnik-Uner PharmD, FCSHP, FASHP, VP of Clinical Content for First Databank (FDB) As the Biden administration ramps up its efforts to increase the access of […]
Data back use of AZ and Pfizer COVID-19 vaccines in older people
Both the Pfizer/BioNTech and Oxford University/AstraZeneca COVID-19 vaccines are highly effective in reducing COVID-19 infections among older people, according to an emerging study data. Data […]
Pfizer vaccine may be less effective in people with obesity, says study
Healthcare workers with obesity found to produce only about half the antibodies healthy people do Coronavirus – latest updates See all our coronavirus coverage The […]
PharmaShots Weekly Snapshots (Feb 22- 26, 2021)
Regeneron Reports IDMC Clearance of Efficacy for REGEN-COV (Casirivimab + Imdevimab) in P-III COVID-19 Outpatient Outcomes Trial Published: Feb 26, 2021 | Tags: Regeneron, Reports, […]
Australia considers approving Pfizer Covid vaccine for standard cold storage
Therapeutic Goods Administration may follow US in allowing vaccines to be stored at warmer temperatures Pfizer’s Covid-19 vaccine could soon be delivered at temperatures 50 […]
Pfizer files tick-borne encephalitis shot with FDA
Pfizer may have been making headlines with the COVID vaccine it developed with BioNTech, but it’s not the only infectious disease the big pharma is […]
Pfizer Reports the US FDA’s Acceptance and Priority Review of BLA for Ticovac (Tick-Borne Encephalitis Vaccine)
Shots: The US FDA has accepted the PR of BLA for TicoVac to prevent TBE in patients aged ≥1year with an anticipated PDUFA date in […]
Number of UK Covid vaccinations falls by a third as vaccine supply dips
Factors at play include high uptake plus stockpiling for second doses, but Matt Hancock promises ‘bumper weeks in March’ Coronavirus – latest updates See all […]
Pfizer, BioNTech ask FDA to approve freezer temp change for Covid-19 vaccine
Pfizer and BioNTech say they have data supporting two-week storage of their vaccine at temperatures found in medical-grade freezers. They say FDA approval of an […]
PharmaShots Weekly Snapshots (Feb 15- 19, 2021)
RedHill Signs a Manufacturing Agreement with Cosmo for Movantik and RHB-204 Published: Feb 19, 2021 | Tags: RedHill, Signs, Manufacturing, Agreement, Cosmo, Movantik, RHB-204 Astellas and […]
Scientists make case for one dose of Pfizer’s COVID jab to stretch supplies
Two researchers have suggested that the second dose of Pfizer and BioNTech’s COVID-19 vaccine could be delayed, as this would increase the number of people […]
Three strategies for managing loss of exclusivity successfully
“Patent losses could sink Allergan”.1 “Drug prices to plummet in wave of expiring patents”.2 “Price decay after loss of brand exclusivity”.3 These are just three […]
South African variant may cut response from Pfizer/BioNTech shot, study finds
The South African coronavirus variant may cut the effectiveness of Pfizer/BioNTech’s vaccine by around two thirds, according to a laboratory study. Researchers from the University […]
Europe orders another 200m doses of Pfizer/BioNTech COVID shot
The European Commission has ordered another 200 million doses of the Pfizer/BioNTech COVID-19 vaccine Comirnaty, bringing the bloc’s total order to 500 million doses. Under […]
North Korea ‘launched cyber-attack on Pfizer for COVID-19 jab data’
A news agency is claiming that North Korea launched a cyber-attack on Pfizer in a bid to steal information about its BioNTech-partnered COVID-19 vaccine, citing […]
Merck gets a leg-up for Keytruda in first-line kidney cancer
New phase 3 data have shored up the position of Merck & Co’s cancer immunotherapy Keytruda in the increasingly competitive first-line kidney cancer market. The […]
Pfizer’s Panzyga Receives the US FDA’s Approval of sBLA for Chronic Inflammatory Demyelinating Polyneuropathy
Shots: The approval is based on the P-III study that involves assessing Panzyga (IVIg) in 142 patients with CIDP. The study evaluated more than one […]
Top 20 Biopharma Deal Terminations of 2020 Based on Total Deal Value
The biopharma industry saw numerous deal terminations in 2020. Clinical and regulatory results, change in control limitations, and strategic reprioritizations were among the most common […]
EU finalises order for 300 million more Pfizer/BioNTech COVID-19 shots
The European Union has rubber-stamped its order for a further 300 million doses of Pfizer/BioNTech’s COVID-19 vaccine, according to press reports. Citing a European Commission […]
PharmaShots Weekly Snapshot (Feb 01-05, 2021)
Reistone Report Results for SHR0302 in P-II Study to Treat Ulcerative Colitis Published: Feb 5, 2020 | Tags: Reiston, Report, Result, SHR0302, P-II, Study, Treat, […]
FDA holds back from action over Xeljanz safety study
The FDA has said it will wait for additional results from last week’s trial showing an increased risk of cardiac side effects with Pfizer’s arthritis […]
Pfizer Signs a License and Research Agreement with Imcyse to Develop Imotopes for Rheumatoid Arthritis
Shots: Imcyse to receive up front, ~$180M as milestones along with royalties. Pfizer to purchase an equity stake in Imcyse Initially, the companies will collaborate […]
One Pfizer/BioNTech jab gives ‘90% immunity’ from Covid after 21 days
New analysis runs counter to earlier study which suggested one dose may not give adequate protection Coronavirus – latest updates See all our coronavirus coverage […]
PharmaShots Weekly Snapshots (Jan 25- 29, 2021)
Roche Collaborate with Cambridge Quantum Computing to Develop Quantum Algorithm for Drug Discovery and Development Published: Jan 29, 2020 | Tags: Roche, Collaborate, Cambridge Quantum Computing, […]
Bad news for Pfizer as blockbuster Xeljanz flunks safety study
JAK inhibitor Xeljanz is one of Pfizer’s top-selling drugs, despite a ‘black box’ warning for blood clots and cancers added to its label in 2019. […]
Bad news for Pfizer as blockbuster Xeljanz flunks safety study
JAK inhibitor Xeljanz is one of Pfizer’s top-selling drugs, despite a ‘black box’ warning for blood clots and cancers added to its label in 2019. […]
Novavax Covid vaccine shown to be nearly 90% effective in UK trial
UK vaccines taskforce has bought 60m doses after study found ‘spectacular results’ Coronavirus – latest updates See all our coronavirus coverage Another vaccine against Covid, […]
Pfizer’s Xeljanz (tofacitinib) Fails to Meet its Co-Primary Endpoint in ORAL Surveillance Safety Study
Shots: The post marketing Oral Surveillance involves assessing the safety of tofacitinib at two doses (5 mg, bid and 10mg, bid) vs TNFi in 4362 […]
Sanofi steps in to boost supplies of Pfizer/BioNTech’s COVID shot
Sanofi has said it is to begin manufacturing the COVID-19 shot from Pfizer and BioNTech in a week when supplies are in the spotlight. The […]
Head of AstraZeneca rejects calls for UK vaccine to be diverted to EU
Chief executive of pharmaceutical giant says the firm will honour UK’s earlier contract despite EU anger over shortfall Coronavirus – latest updates See all our […]
EU means business over Covid vaccine exports, says Von der Leyen
Commission president says firms must deliver on orders after AstraZeneca warns of shortfall Coronavirus – latest updates See all our coronavirus coverage The EU “means […]
Pharmaceutical giants not ready for next pandemic, report warns
Ten of the world’s most infectious diseases identified by the WHO not being catered for by drug firms The world’s biggest pharmaceutical firms are little […]
EU eyes tighter COVID-19 vaccine exports as access gets ugly
The EU has hit back at AstraZeneca’s plan to provide fewer doses of its COVID-19 vaccine than expected, saying it wants to see exactly where […]
Merck, Pfizer get EU nod for Bavencio as bladder cancer maintenance
Pfizer and partner Merck KGaA now have approval on both sides of the Atlantic for their checkpoint inhibitor Bavencio as a first-line maintenance therapy for […]
Aurinia’s Lupkynis for Lupus; FDA Fast Track Designation for Toripalimab; Wren Therapeutics’ Financing; Merck’s Covid-19 Vaccine Program End
Hot on the heels, Aurinia launches its drug in the Lupus market after GSK Aurinia Pharmaceuticals has recently got the USFDA approval for its Lupkynis […]
Vaccine experts call for clarity on UK’s 12-week Covid jab interval
British Society for Immunology calls for a robust programme monitoring the body’s immune response Experts have called for greater clarity on the monitoring in place […]
Vaccine experts call for clarity on UK’s 12-week Covid jab interval
British Society for Immunology calls for a robust programme monitoring the body’s immune response Experts have called for greater clarity on the monitoring in place […]
I’ve had my first vaccine jab. It gives me hope of liberation… but not yet
Exactly a year after his first story about coronavirus, our science editor received the Pfizer injection last week. Here he reflects on a remarkable scientific […]
Vaccine experts defend UK decision to delay second Pfizer Covid jab
Medics told they risk undermining public confidence by querying policy of three-month gap between doses Coronavirus – latest updates See all our coronavirus coverage Leading […]
World’s poor need action, not Covid ‘vaccine nationalism’, say experts
Nations outbidding each other creates an ‘immoral race towards the abyss’ Coronavirus – latest updates See all our coronavirus coverage Pharmaceutical companies should do more […]
Leveraging Technology and Data for COVID-19 Vaccine Distribution
Kevin Grauman, President and CEO, QLess After months of uncertainty, hope is finally on the horizon as three viable COVID-19 vaccine candidates are moving closer […]
Top 20 Life Sciences Deals of 2020 by Total Deal Value
Life sciences companies are gearing up to enter new markets as they look to secure their positions after a spate of M&A, licensing, and research […]
Pfizer/BioNTech say COVID-19 vaccine works against UK variant
Laboratory studies have confirmed that antibodies stimulated by Pfizer and BioNTech’s COVID-19 vaccine can neutralise the new, more transmissible variant of SARS-CoV-2 identified in the […]
Single Covid vaccine dose in Israel ‘less effective than we hoped’
Surge in infections dampens optimism over country’s advanced immunisation programme Coronavirus – latest updates See all our coronavirus coverage Israel’s coronavirus tsar has warned that […]
COVID-19 vaccine supplies in spotlight as immunisation campaigns kick in
Supplies of COVID-19 vaccines are in the spotlight as countries across the world step up their immunisation campaigns against the pandemic. As vaccine manufacturers face […]
EU’s Covid vaccination debacle is down to institutional inflexibility
Supply delays underline there was no legal or economic justification for central planning A storm is raging over the EU’s failure to have ordered more […]
Allergic reactions prompt Moderna COVID vaccine pause in California
Public health authorities in California are seeking a halt on dosing of one lot of Moderna’s COVID-19 vaccine after reports of allergic reactions at one […]
Fauci backs Biden’s plan for 100 million COVID-19 shots
A promise by president-elect Joe Biden to carry out 100 million coronavirus vaccinations in his first 100 days in power is “absolutely doable”, according to […]
UK to face short term delay in delivery of Pfizer vaccine
Overall number of doses delivered between January and March will remain the same, the firm says Coronavirus – latest updates See all our coronavirus coverage […]
PharmaShots Weekly Snapshots (Jan 11 – 15, 2021)
Novartis’ Ligelizumab (QGE031) Receives the US FDA’s Breakthrough Designation for Patients with Chronic Spontaneous Urticaria Published: Jan 15, 2020 | Tags: Novartis’, Ligelizumab (QGE031), Receives […]
J&J single-shot COVID-19 vaccine shows early promise
J&J has announced early trial results that suggest its single-shot coronavirus vaccine provides a sustained response against the virus ahead of a phase 3 trial […]
Pfizer’s Xalkori (crizotinib) Receives the US FDA’s Approval for ALK-Positive Anaplastic Large Cell Lymphoma In Children And Young Adult
Shots: The approval is based on the ADVL0912 study assessing Xalkori in 121 patients aged 1-21yrs. that included 26 patients with r/r, systemic ALK+ ALCL […]
PharmaShots’ Key Highlights of Fourth Quarter 2020
The fourth quarter of 2020 contains multiple initiations of clinical trials, big approvals, and numerous deals. COVID-19 related news remains at the peak in this […]
Tivicay approved in Europe in new dispersible tablet for children with HIV
ViiV’s Tivicay is to become available in Europe in a new dispersible tablet form to treat children living with HIV. The joint venture, majority-owned by […]
Vaccine rollout is an administrative problem, not a distribution issue and is expected to go away
The CEOs of Pfizer, Moderna, McKesson and CVS Health explained that the distribution effort has gone well but the administration of the vaccine has now […]
Hackers posted stolen COVID-19 vaccine info online, says EU regulator
Hackers posted stolen confidential information about Pfizer/BioNTech’s COVID-19 vaccine online, the European Medicines Agency has said in an update. The EMA last month revealed that […]
Netanyahu touts Pfizer deal after 20% of Israelis get Covid jab
Country will share data on its rapid vaccination campaign as ‘global model’, says PM Coronavirus – latest updates See all our coronavirus coverage One in […]
EU plans video summit after doubling supply of Pfizer Covid vaccine
Bloc agrees deal for a further 300m doses as hopes are raised for speedier rate of inoculations Coronavirus – latest updates See all our coronavirus […]
PharmaShots Weekly Snapshot (Jan 4-8, 2020)
Almirall and Tyris Collaborate to Develop Next Generation Gene Therapies Published: Jan 7, 2020 | Tags: Almirall, Tyris, Collaborate, Develop, Next Generation, Gene Therapies Sarepta […]
Pfizer Reports the First Patients Dosing of PF-06939926 in P-III CIFFREO Study for DMD
Shots: The first patient has been dosed in P-III CIFFREO study assessing PF-06939926 vs PBO in 99 ambulatory male patients aged 4-7yrs. with DMD across […]
Pfizer/BioNTech vaccine may work against new virus mutation, scientists say
The Pfizer/BioNTech vaccine appears to work against an important mutation in the new coronavirus variants causing havoc in the UK and South Africa, according to […]
Resourceful or risky? The UK’s controversial COVID-19 vaccine strategy
As COVID-19 vaccines are hastily deployed in the UK for priority groups, a debate rages over the government’s controversial strategy to delay time between vaccine […]
UK left trailing as EU quickly approves Moderna’s COVID-19 vaccine
The European Union has approved the coronavirus vaccine from Moderna, leaving the UK trailing because of changes to post-Brexit drug approval rules. With the UK […]
Pfizer Signs a License and Supply Agreement with ImaginAb for CD8 ImmunoPET Technology
Shots: ImaginAb to receive license fees and payments for manufacturing and other support and will supply clinical doses of 89Zr CD8 Immuno-PET agent to Pfizer […]
Pfizer deal paves way for approval of ImaginAb’s cancer imaging tech
ImaginAb has signed a deal with Pfizer, which it hopes will help it to gather information necessary for approval of its tumour imaging agent as […]
Pfizer Collaborates with Dewpoint to Develop Therapies for Rare Form of Muscular Dystrophy
Shots: Dewpoint to receive up front payment and up to $239M as research, development & commercial milestones along with royalties on sales of the therapies […]
Pfizer drops the blue pill, kicks off 2021 with new DNA logo
Pharma companies are always talking about moving ‘beyond the pill’, and Pfizer’s new brand identity embodies that – it’s decades old pill-like logo has been […]
No data to support UK delay of vaccines’ second dose, says WHO
Move to postpone second jab by up to 12 weeks is not supported by scientific evidence, experts find Coronavirus – latest updates See all our […]
Pfizer/ OPKO Health’s Somatrogon; FDA EU for SCONE device; Antengene ATG-010 for rrMM and rrDLBCL; SanBio STEMTRA Phase 2 Interim Results
Pfizer and OPKO Health: A step closer to FDA Nod for pediatric growth hormone deficiency (GHD) drug, Somatrogon Pfizer and Opko had joined hands in […]
Pfizer and OPKO Reports the US FDA’s Acceptance of BLA for Somatrogon to Treat Pediatric Patients with Growth Hormone Deficiency
Shots: The BLA submission is based on P-lll study assessing the safety and efficacy of Somatrogon (0.66 mg/kg, qw) vs Somatropin (0.034 mg/kg, qd) in […]
Analysis: is it wise for England to mix and match Covid vaccines?
US experts warn against plan to give different second jab if supplies run low Coronavirus – latest updates See all our coronavirus coverage The UK […]
Change in vaccine policy is a high-stakes gamble | Letters
The effectiveness of delaying the second dose of Covid vaccines must be carefully monitored, argues Dr Grizelda George, while Jan Mortimer and Jenny van Tinteren […]
BioNTech criticises EU failure to order enough Covid vaccine
Firm races to fill potential gap left by bloc’s gamble on several vaccines being approved Coronavirus – latest updates See all our coronavirus coverage BioNtech […]
PharmaShots Weekly Snapshots (Dec 28- 31, 2020)
Sinopharm’s COVID-19 Vaccine Demonstrates 79% Efficacy in P-III Study Published: Dec 30, 2020 | Tags: COVID-19, Interim Analysis, New Coronavirus Inactivated Vaccine, P-lll Study, reports, […]
Questions hang over UK’s rollout of Oxford/AstraZeneca jab
Analysis: regulator surprises by approving 12-week gap between first and second shots of vaccine as well as Pfizer/BioNTech shot Coronavirus – latest updates See all […]
AZ COVID-19 vaccine cleared in UK, dosing to start next week
The UK has approved AstraZeneca and Oxford University’s COVID-19 vaccine AZD1222 in another significant step forward in the fight against the pandemic, with first doses […]
‘I’ve never seen anything like it’: 2020 smashes records in global markets
From worst crash in a generation to record highs on news of a Covid vaccine, experts review the rollercoaster that was 2020 Coronavirus – latest […]
Amazon, AstraZeneca, Pfizer, Merck to Build $10M Digital Health Innovation Lab in Israel
Rehovot Science Park What You Should Know: – Pfizer, AstraZeneca, Merck, and Teva, and Amazon Web Services (AWS) has been selected by the Israel Innovation […]
Pfizer Report the US FDA’s Acceptance and Priority Review of sNDA for Lorbrena (lorlatinib) to treat (ALK)-Positive (NSCLC)
Shots: The US FDA has accepted for Priority Review the sNDA is based on the pivotal CROWN study and is being reviewed by the FDA […]
Vulnerable should all get COVID-19 shot before summer, says NHS chief
NHS England’s chief executive Sir Simon Stevens has said that all vulnerable people over the age of 50 will be offered a COVID-19 vaccine by […]
Myovant Signs Agreement with Pfizer to Develop and Commercialize Relugolix in Oncology and Women’s Health
Shots: Myovant & Pfizer will jointly develop & commercialize ORGOVYX (relugolix) in advanced prostate cancer & if approved, relugolix combination tablet in women’s health in […]
A USD 4.2 Billion Myovant/ Pfizer Deal; Audentes Therapeutics’ ASPIRO Trial Free to Proceed; First Generic of Drug for Severe Hypoglycemia Gets Approval; Teleflex Acquires Z-Medica
A USD 4.2 Billion Myovant/ Pfizer Deal Myovant Sciences have decided to put their forces and efforts together to advance the Prostate cancer market as […]
NHS doctors ‘scrabbling’ to get vaccine amid alarm at Covid variant
Many medics ‘frustrated’ about low priority given to frontline staff at high risk of infection Coronavirus – latest updates See all our coronavirus coverage Frontline […]
A year for corporate titans who could lose their shirt and still make a packet
The 2020 Observer Business Agenda Awards honour showoffs, light-touch founders and even … Big Pharma Each year, our awards celebrate the physical prowess of the […]
PharmaShots Weekly Snapshots (Dec 21-23, 2020)
Roche’s Phesgo (Perjeta + Herceptin) Receives EC’s Approval for the Treatment of HER2-Positive Breast Cancer Published: Dec 23, 2020 | Tags: (Perjeta + Herceptin), EC’s […]
AMA Adds 3 Additional CPT Codes for AstraZeneca’s COVID-19 Vaccine
What You Should Know: – The American Medical Association (AMA) announced the addition of three Current Procedural Terminology (CPT) codes for AstraZeneca’s COVID-19 vaccine. The […]
Moderna, Roche team up to track duration of Covid-19 protection after vaccination
Moderna is using a Roche antibody test in clinical trials of its Covid-19 vaccine. The test can measure the antibodies created through vaccination, offering a […]
INVEST Precision Medicine Pitch Perfect winner spotlight: TrialSpark
Judges picked TrialSpark as the winner on the life sciences track of the pitch competition at MedCity’s virtual precision medicine conference. While the company is […]
Pfizer and BioNTech’s Comirnaty (BNT162b2) Receives EC’s Conditional Marketing Authorization for COVID-19
Shots: The approval is based on P-ll/lll study involve the assessment of Comirnaty (BNT162b2) vs PBO in 44,000 patients aged ≥16 yrs. in the ratio […]
‘Highly likely’ BioNTech vaccine will work against new strain, says CEO
BioNTech CEO Ugur Sahin has said that it is “highly likely” the company’s COVID-19 vaccine will work against the more infectious strain circulating in the […]
FDA gives nod to Moderna vaccine for Covid-19
The company’s vaccine is the second approved for emergency use by the FDA. It is expected to pose fewer logistical challenges than the first, which […]
Belgian minister tweets EU’s Covid vaccine price list to anger of manufacturers
Pharmaceutical companies complain of breach of confidentiality after amount EU has agreed to pay for leading vaccines goes public Coronavirus – latest updates See all […]
FDA aims for fast approval of Moderna’s COVID-19 shot after panel vote
The FDA is looking to quickly approve Moderna’s COVID-19 vaccine after it was unanimously backed by a panel of experts. Yesterday’s advisory panel meeting voted […]
Precision measurement in 2021: Why accuracy is key to the vaccine ‘cold chain’ and disrupting the spread of Covid-19
By creating new networks for 24/7 temperature monitoring, alerts and reporting, the challenges of deploying transportation at ultra-low temperatures can be overcome. This also illustrates […]
Trials of Valneva COVID-19 vaccine begin in UK
Trials of a fifth COVID-19 vaccine have begun in the UK, as IT issues threaten to delay the roll-out of the shot from Pfizer/BioNTech. France’s […]
Tensions mount over handling of UK Covid vaccine rollout
With overall costs for vaccinating the UK population at £12bn, the public accounts committee flags ‘highly unusual’ arrangements Coronavirus – latest updates See all our […]
Pfizer/BioNTech COVID-19 vaccinations start across the US
Hospitals in the US have started vaccinating their front-line staff against COVID-19, as deaths in the country crossed the 300,000 threshold with more than 200,000 […]
FTA for Gannex’s ASC4; Disappointment for Incyte’s Ruxolitinib; Historic win for Pfizer, BioNTech’s COVID Vaccine; Alexion buyout; the debut of InnoSkel
Gannex received US FDA fast track designation for its NASH drug, ASC42 an FXR Agonist Gannex Pharma has received Fast Track designation approval from FDA […]
Family doctors begin COVID-19 immunisation drive in UK
The roll-out of the biggest vaccination programme in the history of the UK’s NHS is gathering pace, as family doctors and their teams begin taking […]
Pfizer and BioNTech’s BNT162b2 Receives the US FDA’s EUA to Prevent COVID-19
Shots: Pfizer & BioNTech received the US FDA’s EUA for BNT162b2 for patients aged ≥16yrs with COVID-19. The companies are gathering additional data & prepared […]
FDA gives emergency OK to Pfizer and BioNTech vaccine
The vaccine was developed in record time, a big scientific accomplishment, even though the agency’s move follows an unusual level of pressure from President Trump’s […]
PharmaShots Weekly Snapshots (Dec 7-11, 2020)
Roche Launches Elecsys SARS-CoV-2 Antigen Test to Support High-Volume COVID-19 Testing Published: Dec 11, 2020 | Tags: Antigen, COVID-19, High, Laboratory, Launch, patients, Roche, SARS-CoV-2, […]
FDA advisers vote in favour of Pfizer/BioNTech COVID-19 shot
Advisers to the FDA have voted in favour of approving Pfizer and BioNTech’s COVID-19 vaccine, with a near-unanimous backing from an expert committee. While the […]
Can the UK deliver on the Covid vaccine rollout? | Stephen Buranyi
The challenge of delivering vaccines on this scale are hard, but are firmly within the world of logistics, engineering, and politics Coronavirus – latest updates […]
FDA panel backs use of Pfizer/BioNTech vaccine for Covid-19
The nonbinding recommendation is a final hurdle before an official emergency use authorization for the vaccine, which could be the first shot approved for use […]
Cyberattack targets EMA, hacks COVID-19 vaccine data
The European Medicines Agency (EMA) says it suffered a cyberattack, with documents relating to a Pfizer and BioNTech’s COVID-19 vaccine accessed. In a terse statement, […]
Top 20 Generics Pharma Companies Based On 2019 Revenue
The global generics pharmaceutical market has become an intimidating segment of the pharmaceutical drug market which continuously growing and increasing with its accessibility & benefits […]
Pfizer and BioNTech ‘s BNT162b2 Receive Health Canada Authorization to Combat COVID-19
Shots: Health Canada has granted authorization under interim order for the emergency use of BNT162b2. The distribution of the vaccine in Canada will be prioritized […]
Coronavirus vaccine may have allergy warning in US, says expert
The US government’s coronavirus vaccine chief has said that Pfizer/BioNTech’s vaccine could carry a warning that it should be avoided by people who are prone […]
NHS told not to give Pfizer vaccine to extreme allergy sufferers after two people have reaction
Anyone scheduled to receive vaccine will be asked about history of allergic reactions Coronavirus – latest updates See all our coronavirus coverage Regulators have issued […]
FDA reviewers back Pfizer/BioNTech COVID-19 vaccine ahead of panel
Reviewers from the FDA have given their blessing to the Pfizer/BioNTech COVID-19 vaccine ahead of a key meeting tomorrow – but the regulator noted that […]
Nine out of 10 in poor nations to miss out on inoculation as west buys up Covid vaccines
Billions unlikely to get jabs as rich countries secure 53% of most promising vaccines Coronavirus – latest updates See all our coronavirus coverage Nine out […]
FDA: Pfizer Covid vaccine data fits with guidance on emergency authorization
Comments raise hopes that the vaccine could soon be available to Americans aged 16 and above US Food and Drug Administration (FDA) staff said on […]
First COVID-19 vaccinations begin in UK hospitals
A 90-year-old woman has become the first person given a COVID-19 vaccine as part of the UK’s mass vaccination programme. Margaret Keenan was given the […]
UK faces “V-Day” and largest ever vaccination programme
Tuesday has been dubbed “V-day” in the UK, when the first doses of Pfizer/BioNTech’s coronavirus vaccine will be distributed to the public outside of a […]
Covid vaccine arrives in UK hospitals ready for first jabs
Medical director warns of great hurdles in largest vaccination campaign in UK history Coronavirus – latest updates See all our coronavirus coverage Batches of the […]
Covid-19 vaccine ‘very safe and highly effective’, UK health chief says
Vaccine safety message ‘vitally important’, head of medicines regulator tells Andrew Marr Show Coronavirus – latest updates See all our coronavirus coverage Public health messaging […]
The vaccine miracle: how scientists waged the battle against Covid-19
We trace the extraordinary research effort, from the discovery of the virus’s structure to the start of inoculations this week Coronavirus – latest updates See […]
Covid vaccines offer chance for big pharma to improve its image
They make life-saving medicines, but no one likes them. Could this year be a turning point? Coronavirus – latest updates See all our coronavirus coverage […]
PharmaShots Weekly Snapshot (Nov 30 – Dec 04, 2020)
Richter Acquires Janssen’s Evra Transdermal Contraceptive Patch Assets for $263.5M Published: Dec 3, 2020 | Tags: Asset Purchase Agreement, Evra, Gedeon Richter, Janssen Pharmaceutical, Signs, […]
Valneva accelerates Lyme disease vaccine R&D project with Pfizer
Valneva has said it plans to accelerate research into its Lyme disease vaccine candidate VLA15, bringing forward a trial including children into the first quarter […]
Pfizer cut vaccine production targets because of raw material shortage – reports
Pfizer slashed its production targets for its COVID-19 vaccine because of a lack of raw materials for its supply chain, according to press reports. The […]
Insights+ Key Biosimilars Events of November 2020
Biosimilars are developed to be highly similar versions of approved biologics in terms of safety, purity, and potency. Biosimilars are expected to be a cost-effective […]
Pfizer & BioNTech Receives MHRA’s EUA for BNT162b2 Against COVID-19
Shots: Pfizer & BioNTech reports that the MHRA in the UK has granted a temporary authorization for the EU for BNT162b2 against COVID-19. The distribution […]
Social media erupts as anti-vaxxers respond to COVID-19 vaccine approval
In the midst of the jubilation about the UK’s emergency approval of Pfizer/BioNTech’s COVID-19 shot in the UK came the depressingly inevitable round of anti-vaccine […]
A history of Pfizer
Few companies embody the term ‘pharma giant’ as much as Pfizer. Here we take a look at the colourful history of one of the biggest […]
Pfizer/BioNTech to deliver COVID-19 vaccine to UK after approval
Pfizer and BioNTech are preparing to deliver their COVID-19 vaccine to the UK after the country’s drugs regulator became the first authority in the world […]
BioNTech and Pfizer Report CMA Submission of BNT162b2 to EMA for COVID-19
Shots: The companies have submitted CMA to the EMA for BNT162b2, against COVID-19. The submission completes the rolling review process initiated on Oct 6, 2020 […]
How does the Pfizer/BioNTech vaccine work and who will get it?
Covid vaccine with an efficacy of almost 95% has been authorised by the UK medicines regulator Coronavirus – latest updates See all our coronavirus coverage […]
Pfizer/BioNTech say COVID-19 vaccine could be approved in Europe by year-end
Pfizer and BioNTech have filed their COVID-19 vaccine with the European medicines regulator, paving the way for a potential approval before the end of the […]
UK appoints COVID-19 vaccine rollout minister as country preps for launch
The UK has appointed Nadhim Zahawi as vaccine rollout minister as the country prepares for a potential approval of Pfizer/BioNTech’s ground-breaking COVID-19 vaccine. According to […]
BioNTech’s Covid vaccine is a triumph of innovation and immigration | Hans-Werner Sinn
Pioneered by a Turkish-German couple, its significance exceeds its practical value The world took note when the German startup BioNTech announced its breakthrough in the […]
Concerns emerge after AZ’s lucky vaccine trial ‘mistake’
AstraZeneca may have tried a positive spin on the trial mistake that led to the accidental discovery of the low dose COVID-19 vaccine regime with […]
A vaccine revolution | podcast
Results from clinical trials have shown that the world has three apparently highly effective vaccines for Covid-19. With the race now on for regulatory approval, […]
AstraZeneca, Oxford are latest to unveil Covid-10 vaccine results
The partners pooled results from two trials and two different dosing regimens, one appearing to be more effective than the other. They hope to produce […]
AZ preps filings for COVID-19 jab, UK nears decision on Pfizer rival
AstraZeneca is preparing to file its COVID-19 vaccine with regulators after phase 3 trial results showed it is up to 90% effective. AZ made the […]
The Guardian view on coronavirus and vaccine scepticism: time to act | Editorial
Plans for mass immunisation against Covid-19 are developing fast, but concerns must be addressed In the 1960s, academics studying rumours drew inspiration from epidemiology. They […]
First Americans may get Covid vaccine in December if US approves Pfizer request
Pharmaceutical partners submitted bid to the FDA for vaccine to be reviewed and emergency authorization may occur within weeks It could take as little as […]
PharmaShots Weekly Snapshot (Nov 16-20, 2020)
Eli Lilly and Incyte Receive FDA’s EUA for Baricitinib + Remdesivir to Treat Hospitalized Patients with COVID-19 Published: Nov 20,2020 | Tags: baricitinib, COVID-19, Eli […]
Pfizer/BioNTech prep US COVID-19 vaccine launch after emergency filing
Pfizer and BioNTech have filed for emergency use of their COVID-19 vaccine candidate in the US, paving the way for a launch before year-end. The […]
Pfizer and BioNTech’s BNT162b2 Demonstrates 95% Efficacy in Preventing COVID-19
Shots: The primary efficacy analysis demonstrated that BNT162b2 is 95% effective against COVID-19 beginning 28 days after the first dose. The study evaluated 170 confirmed […]
Pfizer Covid-19 vaccine has 95% efficacy and is safe, further analysis shows
Among first 170 Covid cases in trial, eight had received vaccine and 162 were in placebo group Coronavirus – latest updates See all our coronavirus […]
Standing ovation: Spike Lee to direct musical about Viagra
The director’s next project after Da 5 Bloods is based on a 2018 Esquire article and will be co-written by Kwame Kwei-Armah Spike Lee is […]
Pfizer Launches US Pilot Programme for Delivery and Distribution of COVID-19 Vaccine, BNT162b2
Shots: Pfizer launched a pilot program to support the state’s planning, deployment & administration of the COVID-19 vaccine candidate, to build on coordination with the […]
Pfizer prepares to file COVID-19 shot after reaching safety milestone
Pfizer is preparing to file its COVID-19 vaccine after a trial reached the safety milestone required by US regulators for emergency use, according to press […]
Pfizer begins US pilot delivery programme for COVID-19 vaccine
Pfizer has begun a pilot delivery programme in the US for its experimental COVID-19 vaccine, as the company seeks to overcome logistical challenges caused by […]
Easier distribution may make Moderna’s vaccine much more valuable | Nils Pratley
While Pfizer/BioNTech’s version requires -75C storage, Moderna’s could be easier to roll out A second coronavirus vaccine candidate was always likely to struggle to match […]
Moderna vaccine’s effectiveness bodes well for Oxford/AstraZeneca jab
Phase 3 success rate of 95% for US firm’s treatment is promising for UK vaccine trial Coronavirus – latest updates See all our coronavirus coverage […]
